The Study on Administration of High-Dose Methotrexate in Children with Osteosarcoma / 대한소아혈액종양학회지
Korean Journal of Pediatric Hematology-Oncology
; : 314-321, 1998.
Article
em Ko
| WPRIM
| ID: wpr-169325
Biblioteca responsável:
WPRO
ABSTRACT
PURPOSE: We investigated serum levels of MTX and accompanying organic toxicities after administration of High-Dose Methotrexate (HDMTX). METHODS: We reviewed a total of 42 courses of HDMTX administration in 6 patients who were diagnosed with osteosarcoma in Hanyang University Hospital from 1993 to 1997. The HDMTX was infused at the doses of 8~12 g/m2, and serum levels were assessed. Leucovorin administration was started 20 hours from the beginning of MTX infusion, and continued until the serum MTX level is below 1x10-7 mol/L and toxicities are not detectable. RESULTS: Of 6 patients (4 males and 2 females), mean age at diagnosis was 11.6 years (8.5~15.6 years). Sites of origin included distal femur in 3, proximal tibia in 1, proximal fibula in 1 and proximal humerus in 1. Serum MTX levels were 1.87+/-0.69x10-4 mol/L at 12~23 hours, and 5.10+/-3.22x10-8 mol/L at 120 hrs after HDMTX infusion. Of 42 courses, hematologic toxicity greater than grade III was observed in 19(45.2%) resulting reduction of dose in 2 patients, and hepatic toxicity greater than grade III in 28(67%). The mean ALT levels was 680+/-563 U in 1st day, and mostly normalized in 10th day. Stomatitis was generally mild, except 1 patient with grade III toxicity. No renal or neurologic toxicity was observed, except 1 seizure episode due to SIADH. CONCLUSION: HDMTX with leucovorin in osteosarcoma was well tolerated, and in majority of courses, serum MTX levels returned to non-toxic level after 120 hours and leucovorin will be desirable to administer during at least 5 days.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Convulsões
/
Estomatite
/
Tíbia
/
Osteossarcoma
/
Metotrexato
/
Leucovorina
/
Diagnóstico
/
Fêmur
/
Fíbula
/
Úmero
Tipo de estudo:
Diagnostic_studies
Limite:
Child
/
Humans
/
Male
Idioma:
Ko
Revista:
Korean Journal of Pediatric Hematology-Oncology
Ano de publicação:
1998
Tipo de documento:
Article